Management of Acne



Management of Acne


Peter C. Schalock

Arthur J. Sober



Acne is a polygenic, multifactorial disease that in some form afflicts nearly all adolescents in the United States. It ranges in severity from a few scattered whiteheads and blackheads to disfiguring, painful, deep-seated, pus-filled, and bleeding nodulocystic lesions. About 15% of surveyed patients with acne seek medical care. The primary care physician is in a unique position to identify and treat many acne sufferers. Properly managing acne requires a thorough understanding of the development of acne in all its phases, so that therapy appropriate to the circumstances can be selected from the available modalities. Early effective treatment minimizes the physical scarring of the disease and prevents or reduces equally important psychological distress.


PATHOPHYSIOLOGY AND CLINICAL PRESENTATION (1, 2 and 3)



Clinical Presentations

Acne can be categorized as obstructive or inflammatory; both types of lesions may be present. Obstructive disease results from impaction of horny material, bacteria, and sebum, which dilates follicular ducts and produces closed comedones (whiteheads) and open comedones (blackheads) (Figs. 185-1 and 185-2). Leakage of intrafollicular contents from comedones into the adjacent dermis produces an inflammatory response. Depending on the degree of leakage into the dermis and the amount of material released, inflammatory lesions vary from small, erythematous papules and superficial pustules to deeper pustules and larger, persistent, and occasionally suppurative nodules. Genetic immunologic factors may contribute to an exaggerated inflammatory response and more severe cystic forms of acne.


PRINCIPLES OF THERAPY (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 and 17)

Treatment is often initiated with topical agents, and with progression, systemic agents are added in more severely affected cases. An initial presentation of severe or scarring acne or with clear hormonal factors should hasten the use of systemic agents.


Removal of Acnegenic Factors

Eliminating precipitants is an important component of therapy. Some cosmetics, including makeup, hair sprays, oils, and
moisturizing creams, may be capable of producing comedones, and their use should be reduced or discontinued. The physician should advise against using acnegenic drugs such as androgens, systemic steroids, iodides, and bromides. Other medications such as lithium and epidermal growth factor receptor blockers (erlotinib/gefitinib) can cause acneiform reactions, but discontinuation of these medications is not typically recommended. The role of foods in the pathogenesis of acne is unclear, but recent epidemiologic and pathophysiologic evidence (see earlier discussion) suggests a potential benefit from the reduction of excessive carbohydrate and dairy intake (especially those forms that induce hyperinsulinism; see Chapter 102).

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 23, 2016 | Posted by in CRITICAL CARE | Comments Off on Management of Acne

Full access? Get Clinical Tree

Get Clinical Tree app for offline access